Table 1.

Clinical characteristics

All (N = 15)High amp (N = 7)Low amp (N = 8)
Age
 Median666766
 Range48–7248–7355–72
Sex
 Female6 (40%)4 (57%)2 (25%)
Race
 White11 (73%)7 (100%)4 (50%)
WHO performance status
 Restricted activity10 (67%)4 (57%)6 (75%)
Prior lines of therapy
 Median (range)3 (1–7)2 (1–5)3 (2–7)
 Prior treatment with first-line platinum doublet100%100%100%
Histology
 Squamous cell carcinoma100%100%100%